Latest News
-
Rapid genome sequencing for paediatric patients
Infants in intensive care are to benefit from a new rapid genetic sequencing service, it was announced today. Read more
-
Scientists reveal streptococcal diversity
The genetic diversity of Streptococcus pneumoniae, the bacterium responsible for hundreds of thousands of infant deaths each year, has been unravelled for the first time, it was announced last night. Read more
-
Monkeypox virus can spread in hospital isolation rooms
Monkeypox patients can shed the virus into the surrounding environment, particularly from skin particles and in debris from skin lesions and scabs, a new study has found. Read more
-
New cancer gene test for women
Women who are BRCA1 and BRCA2 negative but have a family history of ovarian, breast and other cancers should be tested for mutations in two other genes, British researchers say. Read more
-
Eye imaging plus AI predicts heart risk
Medical images of the retina can accurately predict an individual’s risk of cardiovascular disease and death, scientists report today. Read more
-
Large study shows brain risk for ex-rugby players
Former international rugby union players may suffer lifelong negative health outcomes, according to research published today highlighting the links between injury and neurodegeneration. Read more
-
Small GP surgeries help to provide personal continuity
Ensuring patients experience personal continuity with a GP is dependent on the characteristics of the practice and the patient and, in particular, on practice size, researchers report today. Read more
-
Concern at hip fractures among intellectual disability patients
People with intellectual disability suffer rates of hip fracture normally seen in patients up to 25 years older than them, according to a new analysis. Read more
-
Breakthrough in understanding cancer metastasis process
One of "the most important findings" about cancer metastasis could revolutionise current thinking, British researchers have announced. Read more
-
NICE turns down gene therapy for Duchenne muscular dystrophy
A gene therapy for treating children with Duchenne muscular dystrophy caused by a ‘nonsense’ mutation has been provisionally rejected by NICE. Read more